INCYTE CORPORATION Restructuring Costs
INCYTE CORPORATION (INCY) reported Restructuring Costs of -$88.00 thousand for the 12-month period ending 2011-12-31, per its 10-K filed 2014-02-21.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:RestructuringCosts · last filed 2014-02-21
- INCYTE CORPORATION restructuring costs for the quarter ending 2011-12-31 was -$108.00K, a 640.00% decline year-over-year.
- INCYTE CORPORATION restructuring costs for the quarter ending 2011-09-30 was $0.00.
- INCYTE CORPORATION restructuring costs for the quarter ending 2011-06-30 was $129.00K.
- INCYTE CORPORATION restructuring costs for the quarter ending 2011-03-31 was -$109.00K.
- INCYTE CORPORATION restructuring costs for fiscal 2011 was -$88.00K.
- INCYTE CORPORATION restructuring costs for fiscal 2010 was -$379.00K, a 118.85% decline from fiscal 2009.
- INCYTE CORPORATION restructuring costs for fiscal 2009 was $2.01M.
| Period end | Restructuring Costs 3 month | Restructuring Costs 6 month | Restructuring Costs 9 month | Restructuring Costs 12 month |
|---|---|---|---|---|
| 2011-12-31 | -$108.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-21 | -$108.00K derived: sum of 2 quarters · filed 2014-02-21 | $21.00K derived: sum of 3 quarters · filed 2014-02-21 | -$88.00K 10-K · filed 2014-02-21 |
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-01 | $129.00K derived: sum of 2 quarters · filed 2012-11-01 | $20.00K 10-Q · filed 2012-11-01 | $40.00K derived: sum of 4 quarters · filed 2013-02-21 |
| 2011-06-30 | $129.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-03 | $20.00K 10-Q · filed 2012-08-03 | $40.00K derived: sum of 3 quarters · filed 2013-02-21 | -$99.00K derived: sum of 4 quarters · filed 2013-02-21 |
| 2011-03-31 | -$109.00K 10-Q · filed 2012-04-26 | -$89.00K derived: sum of 2 quarters · filed 2013-02-21 | -$228.00K derived: sum of 3 quarters · filed 2013-02-21 | -$373.00K derived: sum of 4 quarters · filed 2013-02-21 |
| 2010-12-31 | $20.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-21 | -$119.00K derived: sum of 2 quarters · filed 2013-02-21 | -$264.00K derived: sum of 3 quarters · filed 2013-02-21 | -$379.00K 10-K · filed 2013-02-21 |
| 2010-09-30 | -$139.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-27 | -$284.00K derived: sum of 2 quarters · filed 2011-10-27 | -$399.00K 10-Q · filed 2011-10-27 | |
| 2010-06-30 | -$145.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-28 | -$260.00K 10-Q · filed 2011-07-28 | ||
| 2010-03-31 | -$115.00K 10-Q · filed 2011-05-03 | |||
| 2009-12-31 | $2.01M 10-K · filed 2012-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| IQVIA HOLDINGS INC. (IQV) | United States | $45.926B | 20.54 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |